A citation-based method for searching scientific literature

Roberta Di Caprio, Giuseppina Caiazzo, Sara Cacciapuoti, Gabriella Fabbrocini, Emanuele Scala, Anna Balato. Expert Opin Drug Saf 2020
Times Cited: 10







List of co-cited articles
31 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review.
Vijay Kumari Sandhu, Arvin Ighani, Patrick Fleming, Charles W Lynde. J Cutan Med Surg 2020
13
40

Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies.
Andreas Körber, Charis Papavassilis, Vaishali Bhosekar, Maximilian Reinhardt. Drugs Aging 2018
31
40

Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1-year period.
M Megna, E Cinelli, A Balato, L Gallo, G Fabbrocini. J Eur Acad Dermatol Venereol 2020
8
37

Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.
Ivan S Grozdev, Abby S Van Voorhees, Alice B Gottlieb, Sylvia Hsu, Mark G Lebwohl, Bruce F Bebo, Neil J Korman. J Am Acad Dermatol 2011
36
30

Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Stefano Piaserico, Andrea Conti, Francesco Lo Console, Clara De Simone, Francesca Prestinari, Annamaria Mazzotta, Giulio Gualdi, Claudio Guarneri, Stefania Borsari, Nicoletta Cassano. Acta Derm Venereol 2014
57
30

Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Maria Esposito, Alessandro Giunta, Annamaria Mazzotta, Arianna Zangrilli, Graziella Babino, Mauro Bavetta, Roberto Perricone, Sergio Chimenti, Maria Sole Chimenti. Dermatology 2012
54
30

Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.
J J Crowley, R B Warren, J C Cather. J Eur Acad Dermatol Venereol 2019
37
30

Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis.
Mitsuha Hayashi, Yoshinori Umezawa, Osamu Fukuchi, Toshihiro Ito, Hidehisa Saeki, Hidemi Nakagawa. J Dermatol 2014
47
30


Efficacy and safety of infliximab in psoriatic patients over the age of 65.
Andrea Chiricozzi, Athanasios Pavlidis, Annunziata Dattola, Luca Bianchi, Maria Sole Chimenti, Monika Fida, Rosita Saraceno. Expert Opin Drug Saf 2016
16
30

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.
Alan Menter, Kenneth B Gordon, Craig L Leonardi, Yihua Gu, Orin M Goldblum. J Am Acad Dermatol 2010
106
30

Elderly psoriatic patients under biological therapies: an Italian experience.
F Ricceri, F Bardazzi, A Chiricozzi, P Dapavo, F Ferrara, C Mugheddu, M Romanelli, F Rongioletti, F Prignano. J Eur Acad Dermatol Venereol 2019
17
30

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
Kim Papp, Kristian Reich, Craig L Leonardi, Leon Kircik, Sergio Chimenti, Richard G B Langley, ChiaChi Hu, Randall M Stevens, Robert M Day, Kenneth B Gordon,[...]. J Am Acad Dermatol 2015
320
30


Managing moderate-to-severe psoriasis in the elderly.
Nicola Balato, Cataldo Patruno, Maddalena Napolitano, Angela Patrì, Fabio Ayala, Raffaele Scarpa. Drugs Aging 2014
39
20

A clinical review of phototherapy for psoriasis.
Ping Zhang, Mei X Wu. Lasers Med Sci 2018
86
20

Apremilast efficacy and safety in elderly psoriasis patients over a 48-week period.
M Megna, G Fabbrocini, E Camela, E Cinelli. J Eur Acad Dermatol Venereol 2020
10
20

Psoriasis Pathogenesis and Treatment.
Adriana Rendon, Knut Schäkel. Int J Mol Sci 2019
375
20

Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
M Megna, M Napolitano, N Balato, G Monfrecola, A Villani, F Ayala, A Balato. Clin Exp Dermatol 2016
30
20

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
C Medina, G Carretero, C Ferrandiz, E Dauden, F Vanaclocha, F J Gómez-García, E Herrera-Ceballos, P De la Cueva-Dobao, I Belinchón, J L Sánchez-Carazo,[...]. J Eur Acad Dermatol Venereol 2015
34
20

European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.
A Nast, P I Spuls, G van der Kraaij, P Gisondi, C Paul, A D Ormerod, P Saiag, C H Smith, E Dauden, E M de Jong,[...]. J Eur Acad Dermatol Venereol 2017
81
20

Biologic treatments for elderly patients with psoriasis.
Mami Momose, Akihiko Asahina, Mitsuha Hayashi, Koichi Yanaba, Yoshinori Umezawa, Hidemi Nakagawa. J Dermatol 2017
22
20

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2).
Jeffrey Crowley, Diamant Thaçi, Pascal Joly, Ketty Peris, Kim A Papp, Joana Goncalves, Robert M Day, Rongdean Chen, Kamal Shah, Carlos Ferrándiz,[...]. J Am Acad Dermatol 2017
93
20


Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim A Papp, Howard Sofen, Lluís Puig, Peter Foley,[...]. Lancet 2018
258
20

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Céline Phan, Nathalie Beneton, Juliette Delaunay, Ziad Reguiai, Claire Boulard, Anne-Claire Fougerousse, Elisa Cinotti, Marco Romanelli, Laure Mery-Bossard, Domitille Thomas-Beaulieu,[...]. Acta Derm Venereol 2020
7
28

Etanercept for the treatment of psoriasis in the elderly.
Giuseppe Militello, Amy Xia, Seth R Stevens, Abby S Van Voorhees. J Am Acad Dermatol 2006
31
20


Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials.
Kristian Reich, Kim A Papp, Andrew Blauvelt, Stephen K Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, Nicole Cichanowitz, Qing Li,[...]. Lancet 2017
276
20

Treatment Approaches to Moderate to Severe Psoriasis.
Paolo Gisondi, Micol Del Giglio, Giampiero Girolomoni. Int J Mol Sci 2017
55
20

Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".
Matteo Megna, Anna Balato, Maddalena Napolitano, Lucia Gallo, Francesco Caso, Luisa Costa, Nicola Balato, Raffaele Scarpa. Clin Rheumatol 2018
31
10

Definition of treatment goals for moderate to severe psoriasis: a European consensus.
U Mrowietz, K Kragballe, K Reich, P Spuls, C E M Griffiths, A Nast, J Franke, C Antoniou, P Arenberger, F Balieva,[...]. Arch Dermatol Res 2011
493
10

Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy.
Geetha Krishnamoorthy, Aditya Kotecha, Jason Pimentel. BMJ Case Rep 2019
5
20

Andrological investigations in men treated with acitretin (Ro 10-1670).
E M Parsch, T Ruzicka, B Przybilla, W B Schill. Andrologia 1990
14
10


Drug use and toxicity in psoriatic disease: focus on methotrexate.
William J Taylor, Eleanor Korendowych, Peter Nash, Philip S Helliwell, Ernest Choy, Gerald G Krueger, Enrique R Soriano, Neil J McHugh, Cheryl F Rosen. J Rheumatol 2008
31
10

Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows.
Giuseppina Caiazzo, Gabriella Fabbrocini, Roberta Di Caprio, Annunziata Raimondo, Emanuele Scala, Nicola Balato, Anna Balato. Front Immunol 2018
53
10


Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.
P H Schafer, A Parton, L Capone, D Cedzik, H Brady, J F Evans, H-W Man, G W Muller, D I Stirling, R Chopra. Cell Signal 2014
175
10

Positive effect of nutraceuticals on sperm DNA damage in selected infertile patients with idiopathic high sperm DNA fragmentation.
Andrea Delbarba, Nicola Arrighi, Paolo Facondo, Carlo Cappelli, Alberto Ferlin. Minerva Endocrinol 2020
7
14

Methotrexate and fertility in men.
A El-Beheiry, E El-Mansy, N Kamel, N Salama. Arch Androl 1979
70
10

Diminished ovarian reserve in patients with psoriasis.
Burcu Tuğrul Ayanoğlu, Elif Didem Özdemir, Onur Türkoğlu, Aslıhan Alhan. Taiwan J Obstet Gynecol 2018
11
10

Folate and phototherapy: What should we inform our patients?
Myron Zhang, Gregory Goyert, Henry W Lim. J Am Acad Dermatol 2017
17
10

Acitretin : A Review of its Pharmacology and Therapeutic Use.
Tania Pilkington, Rex N Brogden. Drugs 1992
42
10

Activation of Nrf2 might reduce oxidative stress in human granulosa cells.
Nana Akino, Osamu Wada-Hiraike, Hiromi Terao, Harunori Honjoh, Wataru Isono, Houju Fu, Mana Hirano, Yuichiro Miyamoto, Michihiro Tanikawa, Miyuki Harada,[...]. Mol Cell Endocrinol 2018
30
10



Vitamin D and psoriasis: an update for dermatologists and nutritionists.
Matteo Megna, Maria Ferrillo, Luigi Barrea, Cataldo Patruno, Giovanna Muscogiuri, Silvia Savastano, Gabriella Fabbrocini, Maddalena Napolitano. Minerva Endocrinol 2020
13
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.